Publications dans lesquelles il/elle collabore avec José A. Obeso Inchausti (31)

2013

  1. Ascorbate prevents cell death from prolonged exposure to glutamate in an in vitro model of human dopaminergic neurons

    Journal of Neuroscience Research, Vol. 91, Núm. 12, pp. 1609-1617

2012

  1. Striatal interaction among dopamine, glutamate and ascorbate

    Neuropharmacology, Vol. 63, Núm. 8, pp. 1308-1314

2010

  1. A direct projection from the subthalamic nucleus to the ventral thalamus in monkeys

    Neurobiology of Disease, Vol. 39, Núm. 3, pp. 381-392

  2. Goal-directed and habitual control in the basal ganglia: Implications for Parkinson's disease

    Nature Reviews Neuroscience, Vol. 11, Núm. 11, pp. 760-772

  3. Missing pieces in the Parkinson's disease puzzle

    Nature Medicine, Vol. 16, Núm. 6, pp. 653-661

2009

  1. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders

    The Lancet Neurology, Vol. 8, Núm. 12, pp. 1140-1149

  2. What can man do without basal ganglia motor output? The effect of combined unilateral subthalamotomy and pallidotomy in a patient with Parkinson's disease

    Experimental Neurology, Vol. 220, Núm. 2, pp. 283-292

2008

  1. Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease

    Movement Disorders, Vol. 23, Núm. SUPPL. 3

  2. Lesion of the centromedian thalamic nucleus in MPTP-treated monkeys

    Movement Disorders, Vol. 23, Núm. 5, pp. 708-715

  3. Neuronal activity of the red nucleus in Parkinson's disease

    Movement Disorders, Vol. 23, Núm. 6, pp. 908-911

  4. The basal ganglia in Parkinson's disease: Current concepts and unexplained observations

    Annals of Neurology, Vol. 64, Núm. SUPPL. 2

2007

  1. Bone-marrow-derived cell differentiation into microglia: A study in a progressive mouse model of Parkinson's disease

    Neurobiology of Disease, Vol. 28, Núm. 3, pp. 316-325

  2. Different levodopa actions on the extracellular dopamine pools in the rat striatum

    Synapse, Vol. 61, Núm. 2, pp. 61-71

2005

  1. Optimization of use of levodopa in Parkinson's disease: Role of levodopa-carbidopa-entacapone combination

    Neurologia, Vol. 20, Núm. 4, pp. 180-188

2004

  1. How does Parkinson's disease begin? The role of compensatory mechanisms (multiple letters)

    Trends in Neurosciences

  2. The origin of motor fluctuations in Parkinson's disease: Importance of dopaminergic innervation and basal ganglia circuits

    Neurology, Vol. 62, Núm. 1 SUPPL. 1

2003

  1. Firing regulation in dopaminergic cells: Effect of the partial degeneration of nigrostriatal system in surviving neurons

    European Journal of Neuroscience, Vol. 18, Núm. 1, pp. 53-60

  2. How is firing activity of substantia nigra cells regulated? Relevance of pattern-code in the basal ganglia

    Synapse, Vol. 49, Núm. 4, pp. 216-225

  3. Neuronal activity in the substantia nigra in the anaesthetized rat has fractal characteristics. Evidence for firing-code patterns in the basal ganglia

    Experimental Brain Research, Vol. 151, Núm. 2, pp. 167-172

2002

  1. The basal ganglia and disorders of movement: Pathophysiological mechanisms

    News in Physiological Sciences, Vol. 17, Núm. 2, pp. 51-55